[HTML][HTML] Nutritional status in patients with hepatocellular carcinoma: Potential relevance for clinical outcome

AM van Dijk, BJP Coppens, MA van Beers… - European Journal of …, 2022 - Elsevier
Background Impaired nutritional status is a risk factor for unfavorable outcome in cirrhosis.
Methods In this prospective cohort study in hepatocellular carcinoma patients referred for …

Is sorafenib (S) safe and effective in patients (pts) with hepatocellular carcinoma (HCC) and Child-Pugh B (CPB) cirrhosis?

GK Abou-Alfa, D Amadori, A Santoro, A Figer… - Journal of Clinical …, 2008 - ascopubs.org
4518 Background: S prolongs overall survival (OS) and time to progression (TTP) in pts with
HCC and Child-Pugh A (CPA)(Llovet et al., ASCO 2007). A Phase II study (Ph II) evaluating …

FIB-4 index for assessing the prognosis of hepatocellular carcinoma in patients with Child-Pugh class A liver function

T Ito, T Kumada, H Toyoda, T Tada - Journal of Cancer Research and …, 2015 - Springer
Purpose We evaluated the prognosis of hepatocellular carcinoma (HCC) patients with Child-
Pugh (CP) class A based on FIB-4 index, which is a liver fibrosis marker. Patients and …

Liver failure in patients treated with chemotherapy for colorectal liver metastases: Role of chronic disease scores in patients undergoing major liver surgery. A case …

F Ratti, F Cipriani, M Catena, M Paganelli… - European Journal of …, 2014 - Elsevier
Aim An accurate and noninvasive tool to predict Chemotherapy Associated Liver Injury
(CALI) still lacks. Study aimed to evaluate chronic liver disease scores (Aspartate …

Assessment of hepatic impairment and implications for pharmacokinetics of substance use treatment

AH Talal, CS Venuto, I Younis - Clinical pharmacology in drug …, 2017 - Wiley Online Library
Although the liver is the primary site of metabolism and biliary excretion for many
medications, data are limited on the liver's pharmacokinetic abilities in cirrhosis. Cirrhosis …

Factors impacting prognosis prediction in BCLC stage C and Child-Pugh class A hepatocellular carcinoma patients in prospective clinical trials of systemic therapy

ZZ Lin, C Hsu, FC Hu, YY Shao, DY Chang… - The …, 2012 - academic.oup.com
Background. The purpose of this study was to determine the prognostic significance of
clinical factors and staging systems for survival of hepatocellular carcinoma (HCC) patients …

Hepatocellular carcinoma: epidemiology, screening, and assessment of hepatic reserve

SZ Frager, JM Schwartz - Current Oncology, 2020 - mdpi.com
Hepatocellular carcinoma: epidemiology, screening, and assessment of hepatic reserve Page 1
S138 Current Oncology, Vol. 27, Supp. 3, November 2020 © 2020 Multimed Inc. REVIEW …

[HTML][HTML] Long-term impact of liver function on curative therapy for hepatocellular carcinoma: application of the ALBI grade

H Toyoda, P Lai, J O'Beirne, CC Chong… - British journal of …, 2016 - nature.com
Background: Application of curative therapy for hepatocellular carcinoma is crucially
dependent on underlying liver function. Using the recently described ALBI grade we …

[HTML][HTML] Predicting Post-Hepatectomy Liver Failure in HCC Patients: A Review of Liver Function Assessment Based on Laboratory Tests Scores

A Morandi, M Risaliti, M Montori, S Buccianti, I Bartolini… - Medicina, 2023 - mdpi.com
The assessment of liver function is crucial in predicting the risk of post-hepatectomy liver
failure (PHLF) in patients undergoing liver resection, especially in cases of hepatocellular …

Deterioration of hepatic functional reserve in patients with hepatocellular carcinoma after resection: incidence, risk factors, and association with intrahepatic tumor …

TI Huo, WY Lui, JC Wu, YH Huang, KL King… - World journal of …, 2004 - Springer
Hepatocellular carcinoma (HCC) is frequently associated with liver cirrhosis. Patients with
HCCs undergoing surgical resection may have declining hepatic functional reserve over …